Success Stories: With the Help of Premium Processing, EB-1A Approved Within a Month for An Experimental Therapeutics Fellow from India

 

Client’s Testimonial:

"Thank you!!!! It is great to work with you guys. Very professional and get things done at the end of the day.”


On October 22nd, 2020, we received another EB-1A (Alien of Extraordinary Ability) approval for an Experimental Therapeutics Fellow in the Field of Oncology (Approval Notice).


General Field: Oncology

Position at the Time of Case Filing: Experimental Therapeutics Fellow

Country of Origin: India

Country of Residence at the Time of Filing: India

Approval Notice Date: October 22nd, 2020

Processing Time: 1 month, 5 days (Premium Processing Requested)


Case Summary:

An experimental therapeutics fellow with an MBBS degree engaged our skillful services to build him an EB-1A (Alien of Extraordinary Ability) petition on his behalf. Once he approached us, we commenced evaluating his testimonies and discovered his extraordinary accomplishments, strongly based on his extensive knowledge and experience in the field. We detailed his research focused on studying the genomics of leukemia and related cancers, as well as the development of novel drug treatments. We aimed to validate how our client’s research addressed some of the world’s most pressing issues, including methods for improving cancer research and healthcare for millions of individuals in the United States and worldwide.

His petition packet was prepared with all the following appended details:

  • Publication & Peer-Review Experience: We listed the 15 peer-reviewed scientific articles and 1 book chapter he published in some of the most acclaimed journals in the field. Also, we noted that our client assessed the work of peers 2 times for a discerning journal, affirming the testimony of his actual participation in the scientific community.
  • Citation Count: We recorded his work that accumulated 295 citations from leading researchers from well-regarded institutions and organizations around the world. His publications have been cited by researchers in 28 countries, thereby illustrating that these publications are highly acknowledged in the field of oncology.
  • Letters of Recommendation: Furthermore, we added five recommendation letters in his EB1A petition packet obtained by him from other influential researchers in the field, attesting to the importance of his published body of work. According to one of the recommenders:
“[Client’s] work to develop new treatments for common types of cancer like Leukemia are vital to improving the health and quality of life of the many people living with cancer in the United States.”

Finally, we convinced the USCIS of our client’s valuable research work. We thank him for choosing our law firm to represent his case. Also, we wish him well in his future endeavors.